IP Verse

Janssen Biotech, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Janssen Biotech, Inc.

Patent Number:
EP3177645
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Applicant:
LINDHOFER, HORST, DR.
Opposition Date:
Mar 16, 2021
Patent Number:
EP2780374
Title:
Binding Molecules For Bcma And Cd3
Applicant:
AMGEN INC.
Opposition Date:
Apr 14, 2020
Patent Number:
EP2780375
Title:
Binding Molecules For Bcma And Cd3
Applicant:
AMGEN INC.
Opposition Date:
Apr 14, 2020
Patent Number:
EP2647707
Title:
Cytotoxicity-Inducing Therapeutic Agent
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
May 24, 2019
Patent Number:
EP1810026
Title:
B7-H1 And Methods Of Diagnosis, Prognosis, And Treatment Of Cancer
Applicant:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Opposition Date:
Jan 18, 2019
Patent Number:
EP3209309
Title:
Compositions Comprising Bacterial Strains
Applicant:
4D PHARMA RESEARCH LIMITED
Opposition Date:
Dec 14, 2018

Latest patents of Janssen Biotech, Inc. opposed by its competitors

Patent:
EP3883606
Grant Date:
Oct 4, 2023
Title:
Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody
Oppositions:
5
Patent:
EP2970980
Grant Date:
Jul 27, 2022
Title:
Manufacturing Methods To Control C-Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins
Oppositions:
1
Patent:
EP3827845
Grant Date:
Mar 30, 2022
Title:
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses
Oppositions:
5
Patent:
EP3370770
Grant Date:
Jan 20, 2021
Title:
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses
Oppositions:
3
Patent:
EP2938724
Grant Date:
Oct 28, 2020
Title:
Culturing Of Human Embryonic Stem Cells At The Air-Liquid Interface For Differentiation Into Pancreatic Endocrine Cells
Oppositions:
1
Patent:
EP3219328
Grant Date:
Jun 17, 2020
Title:
Human Anti-Il-23 Antibodies, Compositions, Method And Uses
Oppositions:
2
Patent:
EP2569419
Grant Date:
Mar 20, 2019
Title:
Differentiation Of Human Embryonic Stem Cells
Oppositions:
1

Competitors of Janssen Biotech, Inc.

AMGEN INC.

AMGEN RESEARCH (MUNICH) GMBH

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Want to track Janssen Biotech, Inc.?

Feel free to send us a message here and we will get back to you